Limertinib: Ushering in a New Era of Precision Treatment for Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases, and its treatment has evolved from traditional chemotherapy to a precision medicine era based on...